The MRC randomised-controlled trial of interferon-α, interleukin-2 and 5-fluorouracil vs interferon-α alone in patients with advanced renal cell carcinoma (RE04):: Rationale and progress

被引：7

作者：

Larkin, JMG ^{[1
]}

Gore, ME ^{[1
]}

机构：

[1] Royal Marsden Hosp, London SW3 6JJ, England

来源：

CLINICAL ONCOLOGY | 2005年 / 17卷 / 05期

关键词：

D O I：

10.1016/j.clon.2005.03.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：319 / 321

页数：3

共 27 条

[1] Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha interferon in patients with metastatic renal cell cancer: a phase II study [J].

Allen, MJ ;

Vaughan, M ;

Webb, A ;

Johnston, S ;

Savage, P ;

Eisen, T ;

Bate, S ;

Moore, J ;

Ahern, R ;

Gore, ME .

BRITISH JOURNAL OF CANCER, 2000, 83 (08) :980-985

[2] Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J].

Atkins, MB ;

Hidalgo, M ;

Stadler, WM ;

Logan, TF ;

Dutcher, JP ;

Hudes, GR ;

Park, Y ;

Lion, SH ;

Marshall, B ;

Boni, JP ;

Dukart, G ;

Sherman, ML .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :909-918

[3] Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma:: A prospectively German cooperative renal randomized trial of the carcinoma chemoimmunotherapy group (DGCIN) [J].

Atzpodien, J ;

Kirchner, H ;

Jonas, U ;

Bergmann, L ;

Schott, H ;

Heynemann, H ;

Fornara, P ;

Loening, SA ;

Roigas, J ;

Müller, SC ;

Bodenstein, H ;

Pomer, S ;

Metzner, B ;

Rebmann, U ;

Oberneder, R ;

Siebels, M ;

Wandert, T ;

Puchberger, T ;

Reitz, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1188-1194

[4] INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA AND 5-FLUOROURACIL FOR METASTATIC RENAL-CELL CANCER [J].

ATZPODIEN, J ;

KIRCHNER, H ;

HANNINEN, EL ;

DECKERT, M ;

FENNER, M ;

POLIWODA, H .

EUROPEAN JOURNAL OF CANCER, 1993, 29A :S6-S8

[5]

ATZPODIEN J, 1997, P AN M AM SOC CLIN, V16, pA1164

[6] RETRACTED: Immunotherapy for advanced renal cell cancer - art. no. CD001425.pub2 (Retracted Article) [J].

Coppin, C ;

Porzsolt, F ;

Awa, A ;

Kumpf, J ;

Coldman, A ;

Wilt, T .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)

[7] INTERFERON-ALPHA AND SURVIVAL IN RENAL-CELL CANCER [J].

FOSSA, S ;

JONES, M ;

JOHNSON, P ;

JOFFE, J ;

HOLDENER, E ;

ELSON, P ;

RITCHIE, A ;

SELBY, P .

BRITISH JOURNAL OF UROLOGY, 1995, 76 (03) :286-290

[8] RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY [J].

FYFE, G ;

FISHER, RI ;

ROSENBERG, SA ;

SZNOL, M ;

PARKINSON, DR ;

LOUIE, AC .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :688-696

[9] Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma [J].

Gleave, ME ;

Elhilali, M ;

Fradet, Y ;

Davis, I ;

Venner, P ;

Saad, F ;

Klotz, LH ;

Moore, MJ ;

Paton, V ;

Bajamonde, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1265-1271

[10]

HARRIS DT, 1983, SEMIN ONCOL, V10, P422

← 1 2 3 →